Entos to develop Fusogenix DNA vaccine to prevent COVID-19 infections

This article was originally published here

Compared to traditional vaccines, the DNA-based vaccine will directly induce a plasmid for encoding the antigen against which an immune response is required and depends on the production

The post Entos to develop Fusogenix DNA vaccine to prevent COVID-19 infections appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply